Also found in: Medical.
SPTBSpontaneous Preterm Birth
SPTBSpectrin, Beta, Erythrocytic
SPTBSecondary Power Test Bed
SPTBSecondary Prevention and Translation Branch (US NIH)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
It is best to review TVU CL screening by populations: singletons without prior SPTB, singletons with prior SPTB, and twins (table).
Women with no previous SPTB who are carrying a singleton pregnancy is the population in which TVU CL could have the greatest impact on decreasing SPTB, for several reasons:
More than 90% of these women have risk factors for SPTB. (7,8)
The mRNA expressions of SPTA1, SPTB, and EPB4.1, mainly erythrocyte membrane skeleton protein, were markedly increased after treatment, and the activities of [Na.sup.+][K.sup.+]-ATPtase and T-ATPtase of erythrocyte were also significantly increased, which are the causes of Yisui Shengxue Granule promoting the intact of erythrocyte morphology and the recovery of erythrocyte function.
Eritrosit zan proteinierinin genleri ve kromozomiari Protein Gen Kromozomal yerlesim Alfa spektrin SPTA1 1g22-q23 Beta spektrin SPTB 14823-824,1 Ankirin ANK1 8p11,2 Bant 3 AE1 17q21-q22 Portein 4,1 EPB41 1p36,p34 Protein 4,2 EPB42 15g15-q21 Glikoforin C GYPC 2g14-q21 Tablo 2.
While the overall rate of SPTB at less than 37 weeks did not differ by maternal race (34% vs.
Analyses of pregnancy outcomes by insurance type and maternal race showed that among 187 Medicaid recipients, black women had significantly higher rates of SPTB at less than 37 weeks (42% vs.
Among the 660 women with commercial insurance, while the overall rate of SPTB at less than 37 weeks was similar for white and black women, black women had significantly higher rates of recurrent SPTB at less than 34, 32, 30, and 28 weeks, reported Dr.
A personal history of SPTB of a singleton gestation is one of the strongest risk factors for preterm delivery in a subsequent pregnancy, with an increase in risk of 1.5- to 2.0-fold.
There have been a number of recent randomized controlled trials on progestin supplementation to prevent recurrent SPTB. (table 1).
Therefore, 17P 250 mg IM weekly starting at 16 to 20 weeks until 36 weeks should be recommended to women with singleton gestations and prior SPTB 20 to 36 6/7 weeks." (2) The basis for this recommendation is a number of trials on vaginal progesterone for women with a history of prior SPTB with conflicting results, one trial demonstrating benefit, (6) others demonstrating no benefit.
(7) Cost-effectiveness studies show that TVU CL screening is more effective, and less costly, compared with TAU CL screening, even in singletons without a prior sPTB. (8)